Type 2 Diabetes Mellitus

SEP 8, 2026 · PHASE 1 TRIAL

A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

ClinicalTrials.gov

Phase 1 single-dose pharmacokinetic study in a small, planned cohort with no results yet posted; registry record only describes the protocol.

SEP 1, 2026 · JOURNAL ARTICLE

Gravity, skeletal muscle, and ectopic steatosis: a new framework for insulin resistance in diabetic liver and pancreatic disease.

Journal of Diabetes and Metabolic Disorders

A narrative literature review proposing a novel integrative framework connecting gravity, muscle activity, and ectopic fat to insulin resistance; raises conceptual questions rather than testing them with new empirical data.

AUG 7, 2026 · JOURNAL ARTICLE

Comparative analysis of three standard diagnostic criteria to detect prediabetes and diabetes in first degree relatives of people with T2DM.

Journal of Diabetes and Metabolic Disorders

Cross-sectional prevalence study in a well-defined high-risk population using standard diagnostic criteria; confirms known epidemiology and relative performance of screening methods without a novel intervention or discovery.

JUL 19, 2026

Peptide LKLKLL is a more effective component of Akkermansia muciniphila which regulate glucolipid metabolism through GLP-1/GIP dual modulation.

Gut Microbes

Without an abstract, there is insufficient information to assess the evidence quality, study design, methodology, or clinical relevance of this peptide research.